United States · FDA National Drug Code directory
Excedrin PM Triple Action Caplets
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0067-2056_8304e801-1a21-42b1-ad99-dd8621be478a
- Product NDC
- 0067-2056
- Form
- TABLET, COATED
- Composition / generic term
- Acetaminophen, Aspirin (NSAID) and Diphenhydramine Citrate
- Labeler
- Haleon US Holdings LLC
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20140924
- Source listing expiry
- 20261231
Source-listed ingredients
- ACETAMINOPHEN — 250 mg/1
- ASPIRIN — 250 mg/1
- DIPHENHYDRAMINE CITRATE — 38 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (0067-2056-24) / 24 TABLET, COATED in 1 BOTTLE · 0067-2056-24
- 1 BOTTLE in 1 CARTON (0067-2056-91) / 100 TABLET, COATED in 1 BOTTLE · 0067-2056-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →